Newsletter
Signup
Login
Welcome Guest
Enter Company

Aurobindo Pharma climbs 4% after launch of anti-parathyroid hormone drug in US

The drug is used for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKO) on dialysis
Thu, 11 Jul 2019 11:33:54 +0530

Related News Articles

Loading...

Market blog




NEWS HEADLINES

Top News
Trending News

Advetisement



Opinion Poll